EUROFINS SCIENTIFIC (ESF0.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:ESF0 • FR0014000MR3

68.42 EUR
-1.48 (-2.12%)
Last: Feb 5, 2026, 07:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ESF0. ESF0 was compared to 18 industry peers in the Life Sciences Tools & Services industry. ESF0 has only an average score on both its financial health and profitability. ESF0 has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year ESF0 was profitable.
  • In the past year ESF0 had a positive cash flow from operations.
  • ESF0 had positive earnings in each of the past 5 years.
  • Each year in the past 5 years ESF0 had a positive operating cash flow.
ESF0.DE Yearly Net Income VS EBIT VS OCF VS FCFESF0.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

  • ESF0 has a Return On Assets (3.54%) which is comparable to the rest of the industry.
  • ESF0's Return On Equity of 8.09% is fine compared to the rest of the industry. ESF0 outperforms 61.11% of its industry peers.
  • With a decent Return On Invested Capital value of 9.79%, ESF0 is doing good in the industry, outperforming 72.22% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for ESF0 is in line with the industry average of 9.98%.
  • The last Return On Invested Capital (9.79%) for ESF0 is above the 3 year average (8.70%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.54%
ROE 8.09%
ROIC 9.79%
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ESF0.DE Yearly ROA, ROE, ROICESF0.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • The Profit Margin of ESF0 (5.44%) is comparable to the rest of the industry.
  • ESF0's Profit Margin has improved in the last couple of years.
  • ESF0 has a Operating Margin (15.59%) which is comparable to the rest of the industry.
  • ESF0's Operating Margin has improved in the last couple of years.
  • ESF0's Gross Margin of 23.29% is on the low side compared to the rest of the industry. ESF0 is outperformed by 83.33% of its industry peers.
  • In the last couple of years the Gross Margin of ESF0 has grown nicely.
Industry RankSector Rank
OM 15.59%
PM (TTM) 5.44%
GM 23.29%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
ESF0.DE Yearly Profit, Operating, Gross MarginsESF0.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ESF0 is creating some value.
  • The number of shares outstanding for ESF0 has been reduced compared to 1 year ago.
  • The number of shares outstanding for ESF0 has been increased compared to 5 years ago.
  • Compared to 1 year ago, ESF0 has an improved debt to assets ratio.
ESF0.DE Yearly Shares OutstandingESF0.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ESF0.DE Yearly Total Debt VS Total AssetsESF0.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 2.82 indicates that ESF0 is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of ESF0 (2.82) is comparable to the rest of the industry.
  • ESF0 has a debt to FCF ratio of 5.24. This is a neutral value as ESF0 would need 5.24 years to pay back of all of its debts.
  • The Debt to FCF ratio of ESF0 (5.24) is better than 66.67% of its industry peers.
  • A Debt/Equity ratio of 0.77 indicates that ESF0 is somewhat dependend on debt financing.
  • ESF0 has a Debt to Equity ratio of 0.77. This is comparable to the rest of the industry: ESF0 outperforms 44.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 5.24
Altman-Z 2.82
ROIC/WACC1.1
WACC8.94%
ESF0.DE Yearly LT Debt VS Equity VS FCFESF0.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

  • ESF0 has a Current Ratio of 1.26. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.26, ESF0 is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • ESF0 has a Quick Ratio of 1.19. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of ESF0 (1.19) is better than 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.19
ESF0.DE Yearly Current Assets VS Current LiabilitesESF0.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 16.50% over the past year.
  • Measured over the past years, ESF0 shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.34% on average per year.
  • The Revenue has been growing slightly by 2.53% in the past year.
  • The Revenue has been growing by 8.78% on average over the past years. This is quite good.
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%

3.2 Future

  • Based on estimates for the next years, ESF0 will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.68% on average per year.
  • Based on estimates for the next years, ESF0 will show a small growth in Revenue. The Revenue will grow by 7.25% on average per year.
EPS Next Y18.01%
EPS Next 2Y14.36%
EPS Next 3Y14.31%
EPS Next 5Y15.68%
Revenue Next Year5.1%
Revenue Next 2Y5.44%
Revenue Next 3Y5.93%
Revenue Next 5Y7.25%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ESF0.DE Yearly Revenue VS EstimatesESF0.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
ESF0.DE Yearly EPS VS EstimatesESF0.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 19.01, the valuation of ESF0 can be described as rather expensive.
  • ESF0's Price/Earnings ratio is a bit cheaper when compared to the industry. ESF0 is cheaper than 72.22% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of ESF0 to the average of the S&P500 Index (27.67), we can say ESF0 is valued slightly cheaper.
  • Based on the Price/Forward Earnings ratio of 16.94, the valuation of ESF0 can be described as correct.
  • ESF0's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ESF0 is cheaper than 72.22% of the companies in the same industry.
  • ESF0 is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 27.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.01
Fwd PE 16.94
ESF0.DE Price Earnings VS Forward Price EarningsESF0.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ESF0 is valued cheaper than 83.33% of the companies in the same industry.
  • ESF0's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ESF0 is cheaper than 88.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.89
EV/EBITDA 9.31
ESF0.DE Per share dataESF0.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • ESF0's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of ESF0 may justify a higher PE ratio.
  • ESF0's earnings are expected to grow with 14.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.06
PEG (5Y)1.04
EPS Next 2Y14.36%
EPS Next 3Y14.31%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • ESF0 has a Yearly Dividend Yield of 1.09%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.43, ESF0 pays a better dividend. On top of this ESF0 pays more dividend than 83.33% of the companies listed in the same industry.
  • With a Dividend Yield of 1.09, ESF0 pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.09%

5.2 History

  • The dividend of ESF0 is nicely growing with an annual growth rate of 16.51%!
Dividend Growth(5Y)16.51%
Div Incr Years1
Div Non Decr Years1
ESF0.DE Yearly Dividends per shareESF0.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 54.88% of the earnings are spent on dividend by ESF0. This is a bit on the high side, but may be sustainable.
  • The dividend of ESF0 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP54.88%
EPS Next 2Y14.36%
EPS Next 3Y14.31%
ESF0.DE Yearly Income VS Free CF VS DividendESF0.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
ESF0.DE Dividend Payout.ESF0.DE Dividend Payout, showing the Payout Ratio.ESF0.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

EUROFINS SCIENTIFIC

FRA:ESF0 (2/5/2026, 7:00:00 PM)

68.42

-1.48 (-2.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-29
Earnings (Next)07-21
Inst Owners35.61%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap12.46B
Revenue(TTM)6.89B
Net Income(TTM)375.00M
Analysts68.42
Price Target68.09 (-0.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.09%
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP54.88%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.03%
PT rev (3m)4.36%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.91%
EPS NY rev (3m)2.83%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.32%
Valuation
Industry RankSector Rank
PE 19.01
Fwd PE 16.94
P/S 1.81
P/FCF 15.89
P/OCF 9.48
P/B 2.69
P/tB N/A
EV/EBITDA 9.31
EPS(TTM)3.6
EY5.26%
EPS(NY)4.04
Fwd EY5.9%
FCF(TTM)4.31
FCFY6.3%
OCF(TTM)7.22
OCFY10.55%
SpS37.84
BVpS25.45
TBVpS-3.69
PEG (NY)1.06
PEG (5Y)1.04
Graham Number45.4
Profitability
Industry RankSector Rank
ROA 3.54%
ROE 8.09%
ROCE 12.65%
ROIC 9.79%
ROICexc 10.74%
ROICexgc 34.11%
OM 15.59%
PM (TTM) 5.44%
GM 23.29%
FCFM 11.38%
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ROICexc(3y)9.52%
ROICexc(5y)11.6%
ROICexgc(3y)31.02%
ROICexgc(5y)39.55%
ROCE(3y)11.31%
ROCE(5y)13.7%
ROICexgc growth 3Y-18.17%
ROICexgc growth 5Y3.78%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y6.63%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
F-Score7
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 5.24
Debt/EBITDA 2.1
Cap/Depr 84.98%
Cap/Sales 7.7%
Interest Coverage 9.99
Cash Conversion 77.4%
Profit Quality 209.23%
Current Ratio 1.26
Quick Ratio 1.19
Altman-Z 2.82
F-Score7
WACC8.94%
ROIC/WACC1.1
Cap/Depr(3y)89.21%
Cap/Depr(5y)85.64%
Cap/Sales(3y)8.63%
Cap/Sales(5y)7.99%
Profit Quality(3y)162.79%
Profit Quality(5y)158.88%
High Growth Momentum
Growth
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
EPS Next Y18.01%
EPS Next 2Y14.36%
EPS Next 3Y14.31%
EPS Next 5Y15.68%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
Revenue Next Year5.1%
Revenue Next 2Y5.44%
Revenue Next 3Y5.93%
Revenue Next 5Y7.25%
EBIT growth 1Y14.06%
EBIT growth 3Y-10.93%
EBIT growth 5Y12.66%
EBIT Next Year83.84%
EBIT Next 3Y29.91%
EBIT Next 5Y21.82%
FCF growth 1Y113.26%
FCF growth 3Y-7.69%
FCF growth 5Y25.62%
OCF growth 1Y31.36%
OCF growth 3Y-4.44%
OCF growth 5Y14.24%

EUROFINS SCIENTIFIC / ESF0.DE FAQ

What is the ChartMill fundamental rating of EUROFINS SCIENTIFIC (ESF0.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ESF0.DE.


What is the valuation status for ESF0 stock?

ChartMill assigns a valuation rating of 6 / 10 to EUROFINS SCIENTIFIC (ESF0.DE). This can be considered as Fairly Valued.


What is the profitability of ESF0 stock?

EUROFINS SCIENTIFIC (ESF0.DE) has a profitability rating of 6 / 10.


What are the PE and PB ratios of EUROFINS SCIENTIFIC (ESF0.DE) stock?

The Price/Earnings (PE) ratio for EUROFINS SCIENTIFIC (ESF0.DE) is 19.01 and the Price/Book (PB) ratio is 2.69.


How sustainable is the dividend of EUROFINS SCIENTIFIC (ESF0.DE) stock?

The dividend rating of EUROFINS SCIENTIFIC (ESF0.DE) is 4 / 10 and the dividend payout ratio is 54.88%.